Correlation Between PhaseBio Pharmaceuticals and Resverlogix Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PhaseBio Pharmaceuticals and Resverlogix Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PhaseBio Pharmaceuticals and Resverlogix Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PhaseBio Pharmaceuticals and Resverlogix Corp, you can compare the effects of market volatilities on PhaseBio Pharmaceuticals and Resverlogix Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PhaseBio Pharmaceuticals with a short position of Resverlogix Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of PhaseBio Pharmaceuticals and Resverlogix Corp.

Diversification Opportunities for PhaseBio Pharmaceuticals and Resverlogix Corp

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between PhaseBio and Resverlogix is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding PhaseBio Pharmaceuticals and Resverlogix Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Resverlogix Corp and PhaseBio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PhaseBio Pharmaceuticals are associated (or correlated) with Resverlogix Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Resverlogix Corp has no effect on the direction of PhaseBio Pharmaceuticals i.e., PhaseBio Pharmaceuticals and Resverlogix Corp go up and down completely randomly.

Pair Corralation between PhaseBio Pharmaceuticals and Resverlogix Corp

If you would invest  5.00  in Resverlogix Corp on September 2, 2024 and sell it today you would lose (1.00) from holding Resverlogix Corp or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.4%
ValuesDaily Returns

PhaseBio Pharmaceuticals  vs.  Resverlogix Corp

 Performance 
       Timeline  
PhaseBio Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PhaseBio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, PhaseBio Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Resverlogix Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Resverlogix Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

PhaseBio Pharmaceuticals and Resverlogix Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PhaseBio Pharmaceuticals and Resverlogix Corp

The main advantage of trading using opposite PhaseBio Pharmaceuticals and Resverlogix Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PhaseBio Pharmaceuticals position performs unexpectedly, Resverlogix Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Resverlogix Corp will offset losses from the drop in Resverlogix Corp's long position.
The idea behind PhaseBio Pharmaceuticals and Resverlogix Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing